OGN Organon & Co.
Healthcare$13.43+0.00%OpenMarket Cap: $3.53B
As of 2026-05-26
Valuation
P/E (TTM)
8.52
PEG
—
P/B
3.87
P/S
0.57
EV/EBITDA
8.29
DCF Value
$27.76
FCF Yield
17.4%
Div Yield
0.6%
Margins & Returns
Gross Margin
53.1%
Operating Margin
19.2%
Net Margin
4.0%
ROE
29.9%
ROA
1.9%
ROIC
5.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.46B | 53.6% | $266.0M | $146.0M | $— | $0.02 |
| Q4 null | $1.51B | 50.4% | $235.0M | $-205.0M | $— | $0.02 |
| FY null | $6.22B | 54.1% | $1.28B | $187.0M | $— | $0.34 |
| Q3 null | $1.60B | 53.5% | $358.0M | $160.0M | $— | $0.02 |
| Q2 null | $1.59B | 54.8% | $326.0M | $145.0M | $— | $0.02 |
| Q1 null | $1.51B | 55.6% | $325.0M | $87.0M | $— | $0.28 |
| Q4 null | $1.59B | 56.3% | $296.0M | $109.0M | $— | $0.28 |
| FY null | $6.40B | 58.0% | $1.49B | $864.0M | $— | $1.12 |
| Q3 null | $1.58B | 58.3% | $390.0M | $359.0M | $— | $0.28 |
| Q2 null | $1.61B | 58.4% | $386.0M | $195.0M | $— | $0.28 |
| Q1 null | $1.62B | 59.0% | $414.0M | $201.0M | $— | $0.28 |
| Q4 2023 | $1.60B | 57.3% | $312.0M | $546.0M | $2.13 | $0.28 |